4-Chloro-6-iodoquinazoline

Product Overview

4-Chloro-6-iodoquinazoline is a highly specialized heterocyclic compound serving as a critical building block in modern medicinal chemistry. As a halogenated quinazoline derivative, this molecule features strategic substitution patterns that enable efficient cross-coupling reactions during complex organic synthesis. Our facility produces this intermediate under strict quality control protocols to ensure consistency for downstream pharmaceutical applications.

The presence of both chloro and iodo substituents on the quinazoline core provides versatile reactivity, allowing chemists to selectively functionalize the molecule at specific positions. This chemical is primarily utilized in the research and development of tyrosine kinase inhibitors, which represent a significant class of therapeutic agents in oncology. We maintain robust inventory levels to support both pilot-scale research and large-scale commercial manufacturing needs.

Technical Specifications

Quality assurance is paramount in the supply of pharmaceutical intermediates. Each batch undergoes rigorous analytical testing using high-performance liquid chromatography and nuclear magnetic resonance spectroscopy. The following table outlines the standard physical and chemical parameters for this product.

Industrial Applications

This compound functions as a key precursor in the multi-step synthesis of advanced pharmaceutical agents. Specifically, it is recognized as an essential intermediate in the production pathway of Lapatinib and related salts. The high purity grade we supply ensures minimal impurity carryover into final active pharmaceutical ingredients, thereby facilitating smoother regulatory filings and process validation.

Beyond oncology applications, halogenated quinazolines are increasingly explored in broader therapeutic areas including anti-inflammatory and antiviral research. Our technical team can provide guidance on optimal reaction conditions for nucleophilic substitution or palladium-catalyzed coupling reactions involving this substrate. We support process chemists in optimizing yield and reducing waste during scale-up operations.

Storage and Handling

To maintain stability and prevent degradation, 4-Chloro-6-iodoquinazoline should be stored in a cool, ventilated environment away from direct sunlight and moisture. The material is packaged in standard 25 kg drums lined with protective polyethylene bags to ensure integrity during transit. Custom packaging solutions are available upon request to accommodate specific logistical requirements or smaller research quantities.

Handling procedures should follow standard industrial hygiene practices for fine chemical powders. Personnel are advised to use appropriate personal protective equipment including gloves and respiratory protection when handling bulk quantities. Our supply chain is optimized for global delivery, ensuring timely arrival with full documentation including Certificate of Analysis and safety data sheets.